Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulio Casi

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Opinion in Structural Biology|October 22, 2003
Convergent protein synthesisGiulio Casi, Donald Hilvert
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 7, 2012
Antibody-drug conjugates: basic concepts, examples and future perspectivesGiulio Casi, Dario Neri
Molecular Pharmaceutics|March 5, 2015
Noninternalizing targeted cytotoxics for cancer therapyGiulio Casi, Dario Neri
Pharmacology & Therapeutics|August 6, 2016
Antibody-drug conjugates: Current status and future perspectivesRémy Gébleux, Giulio Casi
Journal of Medicinal Chemistry|June 17, 2015
Antibody-Drug Conjugates and Small Molecule-Drug Conjugates: Opportunities and Challenges for the Development of Selective Anticancer Cytotoxic AgentsGiulio Casi, Dario Neri
Current Opinion in Chemical Biology|March 3, 2015
Small targeted cytotoxics from DNA-encoded chemical librariesFlorent Samain, Giulio Casi
The Journal of Biological Chemistry|August 29, 2007
Reinvestigation of a selenopeptide with purportedly high glutathione peroxidase activityGiulio Casi, Donald Hilvert
Chembiochem : a European Journal of Chemical Biology|June 13, 2008
Selenoglutaredoxin as a glutathione peroxidase mimicGiulio Casi, Gerard Roelfes, Donald Hilvert
Molecular Cancer Therapeutics|September 11, 2014
A chemically defined trifunctional antibody-cytokine-drug conjugate with potent antitumor activityThomas List, Giulio Casi, Dario Neri
Molecular Cancer Therapeutics|April 25, 2014
Antibody-based delivery of IL2 and cytotoxics eradicates tumors in immunocompetent miceKatrin L Gutbrodt, Giulio Casi, Dario Neri
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Opinion in Structural Biology|October 22, 2003
Convergent protein synthesisGiulio Casi, Donald Hilvert
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 7, 2012
Antibody-drug conjugates: basic concepts, examples and future perspectivesGiulio Casi, Dario Neri
Molecular Pharmaceutics|March 5, 2015
Noninternalizing targeted cytotoxics for cancer therapyGiulio Casi, Dario Neri
Pharmacology & Therapeutics|August 6, 2016
Antibody-drug conjugates: Current status and future perspectivesRémy Gébleux, Giulio Casi
Journal of Medicinal Chemistry|June 17, 2015
Antibody-Drug Conjugates and Small Molecule-Drug Conjugates: Opportunities and Challenges for the Development of Selective Anticancer Cytotoxic AgentsGiulio Casi, Dario Neri
Current Opinion in Chemical Biology|March 3, 2015
Small targeted cytotoxics from DNA-encoded chemical librariesFlorent Samain, Giulio Casi
The Journal of Biological Chemistry|August 29, 2007
Reinvestigation of a selenopeptide with purportedly high glutathione peroxidase activityGiulio Casi, Donald Hilvert
Chembiochem : a European Journal of Chemical Biology|June 13, 2008
Selenoglutaredoxin as a glutathione peroxidase mimicGiulio Casi, Gerard Roelfes, Donald Hilvert
Molecular Cancer Therapeutics|September 11, 2014
A chemically defined trifunctional antibody-cytokine-drug conjugate with potent antitumor activityThomas List, Giulio Casi, Dario Neri
Molecular Cancer Therapeutics|April 25, 2014
Antibody-based delivery of IL2 and cytotoxics eradicates tumors in immunocompetent miceKatrin L Gutbrodt, Giulio Casi, Dario Neri
Pageof 2